Article Details
Retrieved on: 2024-03-14 21:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Stockholm, Sweden, 14 March 2024 – Xbrane Biopharma AB (publ) (“Xbrane” or the “Company”) (Nasdaq Stockholm: XBRANE) announced on 22 January 2024, ...
Article found on: www.placera.se
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here